Theophylline Tablet, Extended Release
Product Images NDC 27241-272

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 27241-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

450mg (Theophylline 450mg)

450mg (Theophylline 450mg)
This is a description of a medication product called Theophylline Extended-Release Tablets. Each film-coated extended-release tablet contains 450 mg of Theophylline Anhydrous USP. The product comes in a package of 100 tablets and has a usual dosage specified in the package insert. The package is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F) in a well-closed container. It is distributed by Ajanta Pharma USA Inc. and manufactured in India.*
FDA Label Image

Theophylline (Theophylline Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.